Table 1 Patient characteristics (TLH laparoscopic total hysterectomy, BSO bilateral salpingo-oophorectomy, STLH laparoscopic subtotal hysterectomy)
From: Cystoscopy after total or subtotal laparoscopic hysterectomy: the value of a routine procedure
Characteristics | Phase 1 (January 1998–May 2001) | Phase 2 (June 2001–August 2004) | p-value |
|---|---|---|---|
Number of patients | 203 | 277 | |
Mean age in years (SD) | 49.8 (6.5) | 49.4 (6.7) | 0.46 |
Age range in years | 34–75 | 35–76 | |
Number at menopause | 103 (50.74%) | 135 (48.74%) | 0.66 |
Indications: | |||
Fibroid uterus | 161 (79.31%) | 214 (77.26%) | 0.59 |
Self/familial breast cancer | 5 (2.46%) | 12 (4.33%) | 0.27 |
Menorrhagia | 83 (40.89%) | 105 (37.91%) | 0.51 |
Metrorrhagia | 1 (0.49%) | 3 (1.08%) | 0.64 |
Menometrorrhagia | 47 (23.15%) | 52 (18.77%) | 0.24 |
Cervical intraepithelial neoplasia 2–3 | 1 (0.49%) | 3 (1.08%) | 0.64 |
Recurrent endometrial polyp | 3 (1.48%) | 3 (1.08%) | 0.70 |
Recurrent postmenopausal bleeding | 16 (7.88%) | 26 (9.39%) | 0.56 |
Ovarian cyst | 5 (2.46%) | 11 (3.97%) | 0.36 |
Pelvic pain | 11 (5.42%) | 28 (10.11%) | 0.063 |
Endometrial complex hyperplasia | 9 (4.43%) | 13 (4.69%) | 0.89 |
Endometrial carcinoma | 0 | 9 (3.25%) | 0.012 |
Type of operation: | |||
TLH [TLH+BSO] | 90 [80] (44.33%) | 49 [43] (17.68%) | <0.001 |
STLH [STLH+BSO] | 113 [88] (55.67%) | 228 [158] (82.31%) |